Back

Role of Alanine Transaminase in Retinal Metabolic Homeostasis: Potential therapeutic target in retinal diseases

Chen, Q.; Zhang, T.; Zeng, J.; Yam, M.; Lee, S.; Zhou, F.; Zhu, M.; Zhang, M.; Lu, F.; Du, J.; Gillies, M.; Zhu, L.

2026-04-22 neuroscience
10.64898/2026.04.19.719493 bioRxiv
Show abstract

PurposeAlanine transaminases (ALT), encoded by the GPT gene, catalyzes the reversible conversion of pyruvate and glutamate to alanine and alpha-ketoglutarate, thereby correlating carbohydrate and amino acid metabolism. However, its role in the human neural retina remains unclear. This study aimed to explore the expression, localization, and metabolic function of ALT in the human neural retina and its potential involvement in retinal diseases. MethodsALT1 and ALT2 expression and localization were examined in the retinas of healthy and diabetic retinopathy (DR) donors via immunoblotting and immunofluorescence. ALT function was assessed in ex vivo human retinal explants using pharmacological inhibition with beta-chloro-L-alanine (BCLA), followed by the analyses of enzyme activity, tissue injury, and transcriptomic responses. Stable-isotope tracing with 13C-and 15N-labelled substrates combined with GC-MS was used to define ALT-dependent carbon and nitrogen fluxes in macular and peripheral retinas. Redox level (NADPH/NADP+) was also evaluated under tert-butyl hydroperoxide-induced oxidative stress. ResultsALT1 and ALT2 were both expressed in the human neural retina, with prominent localization in Muller glia and photoreceptor inner segments. ALT1 displayed a diffuse cytoplasmic distribution, whereas ALT2 demonstrated a punctate pattern consistent with mitochondrial localization. In DR retinas, ALT1 expression was spatially disorganized and heterogeneous, while ALT2 remained comparatively preserved. Inhibition of ALT with BCLA markedly reduced ALT activity without causing overt cytotoxicity or major transcriptional changes. Isotope tracing demonstrated that retinal ALT predominantly channels pyruvate-derived carbon into alanine, whereas alanine was minimally contributed to pyruvate production under basal conditions. ALT inhibition suppressed alanine synthesis and release, redirected nitrogen flux towards glutamate, glutamine, and aspartate, and uncovered distinct metabolic adaptations in macular but not peripheral retinas. Under oxidative stress, ALT inhibition induced the decrease of NADP+/NADPH ratio and LDH release, indicating improved redox balance and reduced tissue injury. ConclusionsALT is previously unrecognized as a regulator of carbon and nitrogen partitioner in the human neural retina, contributing to redox homeostasis under stress. The altered distribution of ALT1 in DR retina and the protective metabolic effects of ALT inhibition suggest ALT as a potential contributor to retinal metabolic vulnerability and a candidate therapeutic target in retinal diseases.

Matching journals

The top 13 journals account for 50% of the predicted probability mass.

1
Investigative Opthalmology & Visual Science
37 papers in training set
Top 0.1%
10.4%
2
Redox Biology
64 papers in training set
Top 0.1%
6.5%
3
Scientific Reports
3102 papers in training set
Top 22%
5.0%
4
Investigative Ophthalmology & Visual Science
22 papers in training set
Top 0.1%
4.4%
5
The FASEB Journal
175 papers in training set
Top 0.2%
4.0%
6
Free Radical Biology and Medicine
33 papers in training set
Top 0.1%
3.7%
7
eBioMedicine
130 papers in training set
Top 0.5%
2.8%
8
Metabolites
50 papers in training set
Top 0.3%
2.8%
9
PLOS ONE
4510 papers in training set
Top 47%
2.2%
10
Experimental Eye Research
30 papers in training set
Top 0.3%
2.1%
11
International Journal of Molecular Sciences
453 papers in training set
Top 5%
2.1%
12
Brain Research
35 papers in training set
Top 0.4%
2.1%
13
Antioxidants
25 papers in training set
Top 0.1%
1.9%
50% of probability mass above
14
FASEB BioAdvances
15 papers in training set
Top 0.1%
1.9%
15
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
25 papers in training set
Top 0.3%
1.7%
16
Frontiers in Neurology
91 papers in training set
Top 3%
1.7%
17
Clinical and Translational Science
21 papers in training set
Top 0.4%
1.7%
18
Journal of Neuroinflammation
50 papers in training set
Top 0.4%
1.7%
19
ACS Chemical Neuroscience
60 papers in training set
Top 1%
1.5%
20
Biomolecules
95 papers in training set
Top 0.7%
1.4%
21
iScience
1063 papers in training set
Top 19%
1.4%
22
The FEBS Journal
78 papers in training set
Top 0.4%
1.3%
23
Function
15 papers in training set
Top 0.3%
1.0%
24
Acta Neuropathologica Communications
81 papers in training set
Top 0.9%
0.9%
25
Molecular Neurodegeneration
49 papers in training set
Top 0.7%
0.9%
26
BMJ Open Diabetes Research & Care
15 papers in training set
Top 0.9%
0.8%
27
eLife
5422 papers in training set
Top 55%
0.8%
28
Frontiers in Endocrinology
53 papers in training set
Top 2%
0.8%
29
Frontiers in Medicine
113 papers in training set
Top 6%
0.8%
30
Cell Death & Disease
126 papers in training set
Top 2%
0.8%